# Orilissa

NDC: 0074-0038
Generic name: Elagolix
Labeler / Manufacturer: AbbVie Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20180723

FDA application: NDA210450

## Active ingredients

- ELAGOLIX SODIUM: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0074-0038"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0074-0038
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a86757b3-09c5-fd3b-1223-244e94f50a66